Home > Healthcare > Medical Devices > Therapeutic Devices > Insulin Pump Market

Insulin Pump Market Analysis

  • Report ID: GMI7983
  • Published Date: Jan 2024
  • Report Format: PDF

Insulin Pump Market Analysis

On the basis of product, the market size from the devices segment is projected to reach over USD 12.5 billion by 2032. Insulin pump devices are undergoing continuous advances to cater to the evolving requirements of diabetes management. Manufacturers are integrating features, such as real-time glucose monitoring and smartphone connectivity for enhancing user experience and control. Subsequently, these devices are preferred as they leverage emerging technologies like machine learning and sensor miniaturization. This development will enable more precise insulin delivery tailored to individual needs for ensuring better glucose control and minimizing the risk of complications, thus transforming diabetes care on a global scale.
 

Insulin Pump Market, By End-use (2023)

In terms of end-use, the insulin pump industry from the home care segment is expected to record 12.7% CAGR through 2032, due to increasing usage at homes for providing patients with greater autonomy in managing their diabetes. Individuals are incorporating these pumps into their daily routines for benefiting from continuous glucose monitoring and remote monitoring capabilities. Furthermore, advancements in telemedicine and wearable technology are enabling even more seamless integration into the lives of patients. This ongoing evolution will empower individuals to take charge of their health more effectively for fostering greater independence and improving overall quality of life for those managing diabetes at home.
 

North America Insulin Pump Market, 2020- 2032 (USD Billion)

North America insulin pump market is predicted to record over USD 6 billion by 2032 due to the rising geriatric population and supportive reimbursement policies. Healthcare providers are increasingly recommending insulin pump therapy for elderly patients across the region. Reimbursement policies are being updated to cover a larger portion of pump costs for making these devices more accessible to patients. Furthermore, the  increasing development of more advanced and user-friendly insulin pump technologies tailored to meet the unique needs of elderly diabetes patients will favor the regional industry growth.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The insulin pump market size was valued at over USD 5.2 billion in 2023 and is expected to witness 12.4% CAGR from 2024 to 2032, led by increasing collaborations with technology firms, research institutions, and healthcare providers to enhance device innovation.

The home care segment of market held a robust growth in 2023 and is expected to record 12.7% CAGR through 2032, due to increasing usage at homes for providing patients with greater autonomy in managing their diabetes.

North America insulin pump market held a decent market share in 2023 and is predicted to record over USD 6 billion by 2032, due to the rising geriatric population and supportive reimbursement policies.

Debiotech S.A., F. Hoffmann La, Insulet Corporation, Lenomed Medical, Nipro Corporation, Medtronic plc, Roche AG, MicroPort , Scientific Corporation among others.

Insulin Pump Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 255
  • Countries covered: 22
  • Pages: 120
 Download Free Sample